Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

FDA Approves Welireg for Several Cancers Associated With VHL Disease

August 13th 2021, 3:55pm

Article

The FDA granted approval to Welireg for the treatment of patients with von Hippel-Lindau-associated kidney cancer, CNS hemangioblastomas and pancreatic neuroendocrine tumors.

Vaccine May Improve Survival Outcome in Patients with Newly Diagnosed Brain Cancer

June 14th 2021, 3:00pm

Article

The vaccine significantly improved a survival outcome over standard-of-care treatment in patients with newly diagnosed glioblastoma.

Brain Cancer Interrupted My Life at the Peak of My Career

May 14th 2021, 4:00pm

Article

A long-term brain cancer survivor shares the story of his cancer journey and where it led his life.

The Latest Updates in the Field of Brain Cancer Research

May 14th 2021, 1:00pm

Article

In honor of Brain Cancer Awareness Month, CURE® spoke with an expert about the latest advances that researchers are working on for patients with this disease.

Friday Frontline: Children’s Hospital L.A. Unveils Mural of Chadwick Boseman, Astronaut Michael Collins Dies from Cancer, And More

April 30th 2021, 3:00pm

Article

From a mural of Chadwick Boseman in a Los Angeles children’s hospital to the death of Apollo 11 astronaut Michael Collins, here’s what’s happening in the cancer landscape this week.

Friday Frontline: A 5-Year-Old Celebrates His Final Round of Radiation at A Boston Bruins Game, Exodus Drummer Tom Hunting Announces Cancer Diagnosis, and More

April 16th 2021, 3:00pm

Article

From a 5-year-old with brain cancer celebrating his final round of radiation at a hockey game to a cancer diagnosis for Exodus drummer Tom Hunting, here’s what’s happening in the cancer landscape this week.

FDA Recommends Early Conclusion Following Positive Results of Phase 2 Trial Assessing Novel Therapy in GBM

April 16th 2021, 1:00pm

Article

The FDA has recommended the manufacturer of a cell-based immunotherapy terminate a phase 2 clinical trial assessing its effectiveness in recurrent or progressive glioblastoma early and pursue a phase 3 trial which may lead to an approval.

Improving Outcomes for Patients With Brain Metastases

March 15th 2021, 4:00am

Video

A Caregiver’s Perspective on Treatment Success

March 15th 2021, 4:00am

Video

Feeling Supported During the Diagnosis and Treatment of Brain Metastases

March 15th 2021, 4:00am

Video